How We Got Here
It has been known for decades that there are two isoforms of Stem Cell Factor, a short form and a long form. Based on the research of our scientific founders it was discovered that only the long form of SCF was up regulated at sites of chronic inflammation. It was this discovery that led to the formation of Opsidio and the development of OpSCF.
The Leadership Team
Martin Phillips, MD
Over 30 years experience in academic medicine, pharmaceutical and biotech drug development, CMO of two venture-funded biotechs, angel investing, and philanthropic board service
Nicholas Lukacs, PhD
Professor of Pathology at University of Michigan; 25 years of grant funded research, >350 peer-reviewed papers, journal editor and officer of national societies
COO & CFO
Over 20 years in life sciences providing operational and financial leadership in clinical service companies. Deep experience in building and growing early stage organizations. Active biotechnology angel investor.